Literature DB >> 15090955

High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor?

Chia-Chang Chuang1, Chung-Jye Hung, Ming-Che Tsai, Tria-Ming Yeh, Yin-Ching Chuang.   

Abstract

OBJECTIVE: To determine serum concentrations of macrophage migration inhibitory factor and other cytokines in severe blunt trauma patients in critical settings and to evaluate their association with patient outcome.
DESIGN: Prospective, observational study.
SETTING: Emergency department and surgical intensive care unit of a university hospital. PATIENTS: Fifty-four severe blunt trauma patients with systemic inflammatory response syndrome requiring intensive care, emergency surgical intervention, or both were enrolled in the study. Forty-four patients with minor injuries were the controls.
INTERVENTIONS: Serum macrophage migration inhibitory factor concentrations were measured in the emergency department <4 hrs postinjury (day 1) and the surgical intensive care unit 24 hrs later (day 2). Blood samples for determination of tumor necrosis factor-alpha, interleukin-6, interleukin-8, and interleukin-10 were measured both in patients with severe blunt trauma and in controls. The Acute Physiology and Chronic Health Evaluation II, Injury Severity Score, Revised Trauma Score, and Trauma Revised Injury Severity Score were used for clinical evaluation of trauma severity.
MEASUREMENTS AND MAIN RESULTS: Serum macrophage migration inhibitory factor concentrations were higher in severe blunt trauma patients than in controls; were significantly correlated with Acute Physiology and Chronic Health Evaluation II, Revised Trauma Score, and Trauma Revised Injury Severity Score scores in severe blunt trauma patients but not in controls; and were higher in nonsurvivors than in survivors.
CONCLUSIONS: Our data suggest that the serum macrophage migration inhibitory factor concentration is higher in severe blunt trauma and that it reflects the severity of trauma. The serum macrophage migration inhibitory factor concentration might be a valuable predictor for the outcome of severe blunt trauma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090955     DOI: 10.1097/01.ccm.0000117170.13320.f4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.

Authors:  K Kofoed; J Eugen-Olsen; J Petersen; K Larsen; O Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

Review 2.  Trauma-induced systemic inflammatory response versus exercise-induced immunomodulatory effects.

Authors:  Elvira Fehrenbach; Marion E Schneider
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

3.  Imbalance between macrophage migration inhibitory factor and cortisol induces multiple organ dysfunction in patients with blunt trauma.

Authors:  Mineji Hayakawa; Kenichi Katabami; Takeshi Wada; Yousuke Minami; Masahiro Sugano; Hidekazu Shimojima; Nobuhiko Kubota; Shinji Uegaki; Atsushi Sawamura; Satoshi Gando
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

4.  Kinetics of inflammatory markers following cancer-related bowel and liver resection.

Authors:  Sándor Márton; János Garai; Valéria Molnár; Vera Juhász; Lajos Bogár; Tamás Köszegi; Boglárka Falusi; Subhamay Ghosh
Journal:  Ups J Med Sci       Date:  2010-11-23       Impact factor: 2.384

5.  Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.

Authors:  Nikita M Patel; Noriaki Yamada; Filipe R M B Oliveira; Lara Stiehler; Elisabeth Zechendorf; Daniel Hinkelmann; Sandra Kraemer; Christian Stoppe; Massimo Collino; Debora Collotta; Gustavo Ferreira Alves; Hanna Pillmann Ramos; Regina Sordi; Ingo Marzi; Borna Relja; Gernot Marx; Lukas Martin; Christoph Thiemermann
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

6.  Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach.

Authors:  Daniel Rittirsch; Veit Schoenborn; Sandro Lindig; Elisabeth Wanner; Kai Sprengel; Sebastian Günkel; Barbara Schaarschmidt; Sonja Märsmann; Hans-Peter Simmen; Paolo Cinelli; Michael Bauer; Ralf A Claus; Guido A Wanner
Journal:  Crit Care       Date:  2015-11-26       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.